Resolution of metabolic dysfunction-associated steatohepatitis with estradiol in a transgender female: A case report

By sjmartinez • May 17, 2024

Steiger A, VanderVeen NT, Kang EH, Weimer AK. Resolution of metabolic dysfunction-associated steatohepatitis with estradiol in a transgender female: A case report. JPGN Rep. 2024 Feb 26;5(2):223-227. doi: 10.1002/jpr3.12054. PMID: 38756118; PMCID: PMC11093893.

Tags: chief residents, GAHT, gender‐affirming hormone therapy, General Internal Medicine, MASLD, Med Peds, metabolic dysfunction‐associated steatotic liver disease, NAFLD, NASH, Nonalcoholic fatty liver disease, nonalcoholic steatohepatitis, Publications, Resident, residents, TGD, transgender and gender‐diverse youth

Coffee and tea consumption and the risk of head and neck cancer: An updated pooled analysis in the International Head and Neck Cancer Epidemiology Consortium

Nguyen T, Koric A, Chang CE, Barul C, Radoi L, Serraino D, Purdue MP, Kelsey KT, McClean MD, Negri E, Edefonti V, Moysich K, Zhang[...]

Treatment Response Biomarkers for Systemic Sclerosis-Associated Interstitial Lung Disease

Volkmann ER, Wilhalme H, Tashkin DP, Kim GHJ, Goldin J, Haussmann A, Kuwana M, Roth MD, Assassi S. Treatment Response Biomarkers for Systemic Sclerosis-Associated Interstitial[...]

Small Molecules, Big Results: How JAK Inhibitors Have Transformed the Treatment of Patients with

Fansiwala K, Sauk JS. Small Molecules, Big Results: How JAK Inhibitors Have Transformed the Treatment of Patients with IBD. Dig Dis Sci. 2024 Dec 20.[...]